Gitnux/Report 2026

Fertility Preservation Industry Statistics

The global fertility-preservation service market was estimated at $76.9 million in 2025, explore the figures behind growth, companies and trends.
20Statistics
30Sources
4Sections
1Visuals
13mRead
Fertility Preservation Industry Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The fertility preservation industry at a glance

The global fertility-preservation service market was estimated at $76.9 million in 2025, while U.S. oocyte-banking activity reached 38,126 cycles in 2023, the latest available national cycle data.

$76.9M[13]
Global market size, 2025
6.0%[13]
Forecast CAGR, 2026–2032
38,126[2]
U.S. oocyte-banking cycles, 2023
39.04%[14]
Asia-Pacific fertility-services share, 2025
Market size
The global fertility-preservation service market was estimated at $76.9 million in 2025. A broader fertility-services market, which includes fertility preservation alongside IVF, diagnostics and other services, was valued at $32.38 billion in 2025.[13][14]
Forecast & CAGR
The global fertility-preservation service market is forecast to reach $115 million by 2032, implying a 6.0% CAGR from 2026 to 2032. In the broader fertility-services market, the fertility-preservation segment is projected to grow at a 10.2% CAGR through 2034.[13][14]
Market share & regions
Asia-Pacific accounted for 39.04% of the broader global fertility-services market in 2025. North America reached $10.18 billion in 2025, while the United States was estimated at approximately $10.33 billion in 2026 within that broader market.[14]
Segmentation
Fertility preservation services include oocyte, embryo, sperm and ovarian-tissue cryopreservation, with services delivered through fertility clinics, hospitals and specialist storage providers. In U.S. SART data for 2022, there were 28,207 oocyte-banking cycles and 8,894 embryo-banking cycles for fertility preservation.[2][15]
Key players & concentration
Named providers and technology companies include ReproTech, California Cryobank, Kaiser Permanente, Johns Hopkins Medicine and Guy’s and St Thomas’ Private Healthcare. Publicly available market data identify these companies but do not provide a reliable 2025 concentration ratio for the fertility-preservation service market.[13]
Pricing
The average U.S. egg-freezing cycle cost about $11,000 in 2025, before additional medication and storage charges. Pricing varies by clinic, medication protocol, number of cycles and duration of storage.[16]
Trends, drivers & challenges
Demand is being supported by delayed parenthood, cancer treatment, gender-affirming care, endometriosis and broader acceptance of oocyte cryopreservation. Access remains constrained by high out-of-pocket costs, uneven insurance coverage and limited evidence on eventual live-birth outcomes; ASRM reported that data for medically indicated preservation remain scarce in 2026.[17][16]
Consumer behavior & competition
U.S. planned oocyte cryopreservation patients increased from 4,153 in 2014 to 16,436 in 2021, according to a national database study. Despite rising uptake, a linked analysis found that only 2.5% of 47,363 patients who froze eggs between 2014 and 2020 had returned to warm and use them during the study period.[17][18]
M&A
On December 2, 2024, Astorg completed the take-private acquisition of Hamilton Thorne and the simultaneous acquisition of Cook Medical’s Reproductive Health business, combining ART equipment, consumables, software and services into a larger global reproductive-health platform.[19]
Regulation
U.S. coverage rules remain fragmented: as of November 2025, 23 states required private insurers to cover at least some infertility services and 18 required some Medicaid coverage, according to KFF. The Alliance for Fertility Preservation’s coverage map was updated on June 24, 2026 and tracks state requirements for egg, embryo, sperm and ovarian-tissue banking.[20][7]
Latest news
The most recent major clinical guidance identified in the search was ASRM’s 2026 committee opinion on fertility preservation for medical indications, which noted that pregnancy and live-birth data after medically indicated oocyte cryopreservation remain limited. Commercially, California’s fertility-coverage expansion began applying to large-group plans in January 2026, increasing the potential addressable population for covered services.[20]

02 Ranking

Top 10 Companies in the Fertility Preservation Industry

The leading companies in the fertility preservation industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 18, 2026 · Next review December 18, 2026

Verdict

IVIRMA Global stands out for oocyte vitrification delivery because it operates more than 200 clinics across 14 countries, while Cryos International focuses on international sperm and egg banking since it ships donor material to more than 100 countries.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in oocyte vitrification

    IVIRMA Global

    ES

    Ranked #1 · 9.3 · Oocyte vitrification

    Why we picked it: It operates a multi-clinic model for oocyte vitrification across 14 countries.

  2. Leader in sperm and egg banking

    Cryos International

    DK

    Ranked #2 · 9.2 · Sperm and egg banking

    Why we picked it: Its cross-border banking is built around shipping donor sperm and egg material to 100+ countries.

  3. Leader in donor tissue storage

    Inception Fertility

    US

    Ranked #4 · 8.8 · Donor tissue storage

    Why we picked it: It combines a frozen donor-egg bank with HavenCryo for tissue storage for fertility-care pathways.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the fertility preservation industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

IVIRMA Global

Oocyte vitrification · ES

9.3
2

Cryos International

Sperm and egg banking · DK

9.2
3

CooperCompanies

Sperm and egg banking · US

9.1
4

Inception Fertility

Donor tissue storage · US

8.8
5

Ovation Fertility

Off-site cryostorage · US

8.8
6

Pinnacle Fertility

US fertility clinics and egg freezing · US

8.7
7

Reprotech

Long-term reproductive-tissue cryostorage · US

8.7
8

Genea

Australian fertility clinics and embryo banking · AU

8.5
9

Monash IVF Group

Australian fertility clinics and cryopreservation · AU

8.0
10

Extend Fertility

Dedicated US egg-freezing practice · US

7.6

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 18, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the fertility preservation industry. In Fertility Preservation Industry Statistics. Gitnux. https://gitnux.org/fertility-preservation-industry-statistics/#top-companies

report visual · Projection

Freeze-all-oocyte cycles recorded in the FertiPROTEKT registry (Germany, Austria and parts of Switzerland)

Freeze-all-oocyte cycles recorded in the FertiPROTEKT registry grew from 176 cycles in 2017 to 615 cycles in 2022.

176 cycles
Start
+28.43%
CAGR · 5y
615 cycles
Projected
20172022
source-verifiedkup.at2022

04 Statistics

Market Intelligence

Market Intelligence quantifies both clinical banking and related concierge activity, including USD 5.1 billion global 2025 value for egg-freezing and embryo-banking services.

Market size and service revenue in the fertility preservation industry

  • USD 4,645.8 million was global 2023 revenue for egg freezing and embryo banking services, defined as egg-freezing and embryo-banking market revenue.[1]
  • 38,930 oocyte-banking cycles for fertility preservation were reported in the United States in 2024 by SART member clinics.[2]
  • USD 5.1 billion was the global 2025 market value for egg freezing and embryo banking services, defined as clinical preservation and banking services for eggs and embryos.[3]
  • 12,427 embryo-banking cycles for fertility preservation were reported in the United States in 2024 by SART member clinics.[2]
  • USD 2.36 billion was the estimated global 2025 market for fertility-preservation concierge services, defined as navigation, benefit administration and care-coordination services.[4]

Growth forecasts for the fertility preservation industry

  • Global fertility-preservation concierge-services revenue is projected to reach USD 32.50 billion by 2036 from USD 3.0 billion in 2026, at a 26.9% CAGR; the study was published in 2026.[4]
  • The global egg-freezing and embryo-banking market is projected to reach USD 13,779.8 million by 2030, at a 16.8% CAGR from 2024 to 2030; the study was published in 2026.[1]
  • The global egg-freezing and embryo-banking market is projected to reach USD 13.6 billion by 2035 from USD 5.6 billion in 2026, implying a 10.3% CAGR; the study was published in 2026.[3]

05 Statistics

Strategy & Growth

Strategy & Growth highlights the independent-practice mix and deal flow, including that 467 U.S. fertility practices were covered by the 2024 Fertility Practice Ownership List.

M&A and consolidation in the fertility preservation industry

  • Approximately 50% of U.S. fertility practices were single-reproductive-endocrinologist practices in the 2024 ownership-list analysis, indicating a substantial independent-practice segment.[5]
  • 467 U.S. fertility practices were covered by the 2024 Fertility Practice Ownership List, documenting ownership structures across the national fertility-services sector.[5]
  • Six U.S. states—California, New York, Texas, Florida, New Jersey and Illinois—accounted for 56% of remaining independent fertility practices in the 2024 ownership-list analysis.[5]
  • 11 fertility-services deals were agreed in North America during January–September 2024, compared with 13 during the same period in 2022, according to Mergermarket data.[6]

06 Statistics

Pricing

Pricing sets an operational cost frame: the average U.S. egg-freezing cycle costs about $11,000 in 2025, before medication and storage charges.

Fees and price levels in the fertility preservation industry

  • $15,000–$20,000 is the typical service fee for embryo freezing in the U.S., with storage priced at $2,000–$15,000 per year; the source defines fertility preservation services broadly.[7]
  • $8,000 is Reach Fertility’s listed fertility-preservation package price in the U.S.; medications, post-cycle care and anesthesia are excluded from the estimate.[8]
  • $1,161 per completed appointment is the estimated semen-cryopreservation fee at the University of Michigan, and annual sperm storage is $990.[9]
  • $756 per year is Reach Fertility’s listed storage fee per specimen type in the U.S.; the alternative monthly tariff is $70.[8]
  • $10,000–$15,000 is the typical U.S. service fee for egg freezing, with storage priced at $500–$1,000 per year; the source defines fertility preservation services broadly.[7]

07 Statistics

Risk & Compliance

Risk & Compliance quantifies exposure in U.S. systems, including that 95% of U.S. fertility clinics were affected by the May 2023 MOVEit security incident.

Incidents, safety and loss events in the fertility preservation industry

  • 95% of U.S. fertility clinics were affected by the May 2023 MOVEit security incident involving ART surveillance data transfers.[10]
  • 4 Maryland residents were identified as affected by IVF Michigan’s February 2023 ransomware incident involving fertility-treatment information.[11]
  • 14 field safety notices were issued in the United Kingdom in 2024/25 for medical devices used in licensed fertility clinics.[12]

Key questions about the fertility preservation industry

What is the size of the global fertility-preservation service market in 2025?
The global fertility-preservation service market was estimated at $76.9 million in 2025.
How fast is the fertility-preservation service market expected to grow after 2026?
The global fertility-preservation service market is forecast to reach $115 million by 2032, implying a 6.0% CAGR from 2026 to 2032.
Which companies lead the fertility preservation industry?
IVIRMA Global stands out for oocyte vitrification delivery because it operates more than 200 clinics across 14 countries, while Cryos International focuses on international sperm and egg banking since it ships donor material to more than 100 countries.
What technology shifts are showing up in the demand patterns for fertility preservation?
Demand is supported by delayed parenthood, cancer treatment, gender-affirming care, endometriosis and broader acceptance of oocyte cryopreservation. Utilization lags: only 2.5% of 47,363 patients who froze eggs between 2014 and 2020 returned to warm and use them during the study period.
How concentrated is growth geographically within fertility services?
Asia-Pacific accounted for 39.04% of the broader global fertility-services market in 2025, indicating concentrated activity outside North America.
What does U.S. national cycle data show for oocyte and embryo banking activity?
In U.S. SART data for 2022, there were 28,207 oocyte-banking cycles and 8,894 embryo-banking cycles for fertility preservation. U.S. oocyte-banking activity reached 38,126 cycles in 2023.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). Fertility Preservation Industry Statistics. Gitnux. https://gitnux.org/fertility-preservation-industry-statistics
MLA
Samuel Norberg. "Fertility Preservation Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/fertility-preservation-industry-statistics.
Chicago
Samuel Norberg. 2026. "Fertility Preservation Industry Statistics." Gitnux. https://gitnux.org/fertility-preservation-industry-statistics.